|
Originally published In Press as doi:10.1074/jbc.M000445200 on March 31, 2000
J. Biol. Chem., Vol. 275, Issue 23, 17412-17419, June 9, 2000
TREK-2, a New Member of the Mechanosensitive Tandem-pore
K+ Channel Family*
Hyoweon
Bang ,
Yangmi
Kim, and
Donghee
Kim§
From the Department of Physiology and Biophysics, Finch University
of Health Sciences/The Chicago Medical School,
North Chicago, Illinois 60064
Received for publication, January 20, 2000, and in revised form, March 23, 2000
 |
ABSTRACT |
Recently, several mammalian K+
channel subunits (TWIK, TREK-1, TRAAK, and TASK) possessing four
transmembrane segments and two pore-forming domains have been
identified. We report the cloning of a new member of this tandem-pore
K+ channel from a rat cerebellum cDNA library. It is a
538-amino acid protein and shares 65% amino acid sequence identity
with TREK-1. Therefore, the new clone was named TREK-2. Unlike TREK-1, whose mRNA has been reported to be expressed in many different tissues, TREK-2 mRNA is expressed mainly in the cerebellum, spleen, and testis as judged by reverse transcriptase-polymerase chain reaction
and Northern blot analysis. Expression of TREK-2 in COS-7 cells induced
a time-independent and non-inactivating K+-selective
current. TREK-2 was partially blocked (36%) by 2 mM Ba2+. In symmetrical 150 mM KCl, the
single-channel conductances were 110 picosiemens at 40 mV and 68 picosiemens at +40 mV, and the mean open time was 0.9 ms at 40 mV.
TREK-2 was activated by membrane stretch or acidic pH. At 40 mm Hg
pressure, channel activity increased 10-fold above the basal level.
TREK-2 was also activated by arachidonic acid and other naturally
occurring unsaturated free fatty acids. These results show that TREK-2
is a new member of the tandem-pore K+ channel family and
belongs to the class of mechanosensitive and fatty acid-stimulated
K+ channels.
 |
INTRODUCTION |
Molecular cloning has identified a large number of K+
channel subunits consisting of two, four, six, and eight transmembrane segments (1-3). Despite the structural diversity, all K+
channels share a conserved pore-forming domain that is essential for
providing K+ selectivity (4, 5). The most recently
identified members of the K+ channel family are those that
possess two pore
(2P)1-forming domains and
four transmembrane (4TM) segments (3, 6-8). The genes for the 2P/4TM
K+ channels were first identified in the nematode
Caenorhabditis elegans (9) and subsequently in other
organisms. Numerous members of the 2P/4TM K+ channel family
(KCNKx) have now been identified in mammalian tissues and
one member from Drosophila (ORK1) (6). Some of the cloned
2P/4TM K+ channel subunits form functional K+
channels when expressed either in Xenopus oocytes or in
mammalian cell lines and exhibit properties of a background
K+ current (7, 10-16). Those that do not express in the
plasma membrane may be targeted to intracellular organelles or need a partner for functional expression (17, 18).
In the 2P/4TM K+ channel family, two members have been
named TREK-1 (TWIK-related K+ channel) and TRAAK
(TWIK-related arachidonic acid-stimulated K+ channel).
TREK-1 and TRAAK are activated by either membrane stretch or free fatty
acids (19, 20). Thus, they may represent the native mechanosensitive
and fatty acid-sensitive K+ channels that were identified
earlier in various cell types (21-24). In cardiac and neuronal cells,
arachidonic acid has been shown to cause opening of three types of
K+ channels (KFA channels) whose
current-voltage relationships are outwardly rectifying, inwardly
rectifying, or linear (24). Based on the reported electrophysiological
and pharmacological characteristics (10, 12), TREK-1 is most likely to
encode the K+ channel that has an outwardly rectifying
current-voltage relationship.
In this study, we report the cloning of a new member
(TREK-2)2 of the 2P/4TM
K+ channel family whose single-channel current-voltage
relationship shows inward rectification. TREK-2 shares 65 and 45%
amino acid identities with TREK-1 and TRAAK, respectively, but <30%
with other 2P/4TM K+ channels. Our results show that TREK-2
is mainly expressed in the cerebellum. When expressed in COS-7 cells,
TREK-2 exhibits an instantaneous and non-inactivating
K+-selective current with high sensitivity to mechanical
stretch and free fatty acids and shows biophysical properties nearly
identical to those of the inwardly rectifying K+ channel
previously described in the rat brain (24).
 |
MATERIALS AND METHODS |
Library Screening--
Total RNA from rat cerebellum was
reversed-transcribed using oligo(dT) to generate first strand cDNA
(Superscript pre-amplification system, Life Technologies, Inc.). A DNA
fragment of 421 bp was obtained by RT-PCR using TRAAK-specific primers
(5'-CAATAGCAGCAACCACTC-3' and 5'-GTACATAATCGCCAAAGC-3'). The DNA
fragment was labeled with 32P and used to screen the rat
cerebellum cDNA library ( ZAP II, Stratagene, La Jolla, CA).
Hybridization was carried out in 20% formamide, 5× SSC, 5×
Denhardt's solution, 0.5% SDS, and 0.2 mg/ml salmon sperm DNA at
42 °C for 15 h. Filters were washed twice with the solution
containing 2× SSC and 0.1% SDS for 15 min at room temperature. Of
1 × 106 phages screened, 12 positive clones were
obtained from the cerebellum cDNA library. DNA inserts were excised
from the ZAP II vector into pBluescript SK and
analyzed by restriction analysis. Four DNA inserts were sequenced using
the dideoxynucleotide chain termination method. One clone (1.45 kb)
contained a partial sequence of a new 4TM K+ channel as
judged by the presence of two pore-forming domains. The same cDNA
library was screened again with a 921-bp DNA fragment obtained by
cutting with EcoRI. Two positive clones included the entire
coding region of a new 4TM K+ channel (pBS-TREK-2).
Northern Blot Analysis and RT-PCR--
Rat multiple-tissue
Northern blots were purchased from CLONTECH (Palo
Alto, CA) and OriGene Technologies, Inc. (Rockville, MD). The membranes
were prehybridized for 30 min at 65 °C and hybridized for 3 h
at 65 °C in ExpressHyb solution (CLONTECH) with
a 32P-labeled 597-bp DNA fragment following the
manufacturer's protocol. This DNA fragment is part of the C terminus
of TREK-2 and was obtained by PCR using pBS-TREK-2 as template and
TREK-2-specific primers (5'-GGCTAATGTCA CTGCTGAGTTCC-3' and
5'-AAGCCACACTTTAGTCCAGCT CC-3'). The membranes were rinsed with
solution containing 2× SSC and 0.05% SDS for 40 min at room
temperature. A second washing was performed in solution containing
0.1× SSC and 0.1% SDS for ~50 min at 50 °C. The membranes were
exposed to an x-ray film and developed 24-36 h later. The membranes
were probed again with 32P-labeled -actin DNA.
For RT-PCR, total RNAs were extracted from 14 rat tissues (RNA STAT-60,
TEL-TEST Inc.), and their integrity was checked by gel electrophoresis.
Total RNAs were reverse-transcribed using an oligo(dT) primer using the
Superscript pre-amplification system. The first strand cDNA was
used as template for PCR amplification using rat TREK-2 primers that
yield the 597-bp TREK-2 fragment (see above). As a control,
glyceraldehyde-3-phosphate dehydrogenase was amplified using specific
primers (CLONTECH). PCR amplification was performed
as follows: initial denaturation at 94 °C for 3 min; 30 cycles at
94 °C for 45 s, 55 °C for 1 min (60 °C in the case of
glyceraldehyde-3-phosphate dehydrogenase), and 72 °C for 2 min; and
a final extension step at 72 °C for 8 min.
Transfection of TREK-2 into COS-7 Cells--
For transfection
into COS-7 cells, the coding region of rat TREK-2 was subcloned into
the pcDNA3.1 vector (Invitrogen, Carlsbad, CA) by ligating into the
EcoRV-XhoI site after cutting pBS-TREK-2 with
SmaI and XhoI. Cells were seeded at a density of
2 × 105 cells/35-mm dish 24 h prior to
transfection. pcDNA3.1/TREK-2 and pcDNA3.1/GFP were
cotransfected into COS-7 cells with LipoTaxi reagent (Life
Technologies, Inc.). Green fluorescence from cells expressing GFP was
detected using a Nikon microscope equipped with a mercury lamp light
source. Cells were used 1-3 days after transfection.
Electrophysiological Studies--
Electrophysiological recording
was performed in the whole-cell, cell-attached patch, inside-out patch,
and outside-out patch configurations using a patch clamp amplifier
(Axopatch 200, Axon Instruments, Inc., Foster City, CA). In experiments
using excised patches, pipettes and bath solutions contained 150 mM KCl, 2 mM MgCl2, 5 mM EGTA, and 10 mM HEPES (pH 7.3). In
whole-cell recordings, the bath solution contained 145 mM
NaCl, 5 mM KCl, 2 mM MgCl2, and 10 mM HEPES (pH 7.3). All recordings were performed at room temperature (22-24 °C). Currents were digitized with a digital data
recorder (VR10, Instrutech, Great Neck, NY) and stored on videotape.
The recorded signal was filtered at 5 kHz using an 8-pole Bessel filter
( 3 dB; Frequency Devices, Haverhill, MA) and transferred to a
computer (Dell) using the Digidata 1200 interface (Axon Instruments,
Inc.) at a sampling rate of 20 kHz. Whole-cell and single-channel
currents were analyzed with the pClamp program (Version 7). Data were
analyzed to obtain a duration histogram, an amplitude histogram, and
relative channel activity (relative NPo). The filter
dead time was ~100 µs (0.3/cutoff frequency). Therefore, events
shorter than ~50 µs will be missed in our analysis. When studying
the effect of membrane tension and free fatty acids using patches that
contain many channel openings (more than five channel levels), currents
were integrated over time to determine the relative channel activity.
N is the number of channels in the patch, and
Po is the probability of a channel being open.
NPo was determined from ~1 min of current
recording. Current tracings shown in the figures were filtered at 1 kHz. Data are represented as mean ± S.D. Student's t
test was used to test for significance at the level of 0.05. All free
fatty acids in liquid form were first dissolved in chloroform and kept in a 80 °C freezer. The solvent (chloroform) was evaporated, and
free fatty acids were dissolved by sonicating for 10 min (Heat Systems-Ultrasonics, Inc., Farmingdale, NY) in bath recording solution
at a desired concentration. Free fatty acids in powder form were
dissolved in ethanol. The final ethanol or Me2SO
concentration in the perfusion solution used was <0.1% and had no
effect on the TREK-2 channel activity. All free fatty acids were
purchased from Sigma. Negative pressure was applied using a plastic
syringe via tubing connected to the pipette holder and monitored using a mercury manometer attached in parallel to the tubing. A steady negative pressure could be obtained using this system. H-7
(1-(5-isoquinolinylsulfonyl)-2-methylpiperazine) was purchased from
Calbiochem. All other chemicals and drugs were from Sigma.
 |
RESULTS |
Cloning of TREK-2--
A 421-bp DNA fragment from rat TRAAK was
used to screen a rat cerebellum cDNA library under mild stringency
conditions. Two positive clones containing a coding region of a new
2P/4TM K+ channel subunit was identified. The DNA sequence
revealed an open reading frame of 1617 bases that encodes a 538-amino
acid polypeptide with a calculated molecular mass of 60 kDa (Fig.
1A). A stop codon (TAA) was
present in the 5'-region upstream of the first methionine, indicating
that the DNA contains the complete coding sequence for a protein.
Hydrophobicity analysis (25) of the amino acid sequence showed that the
new clone belongs to the K+ channel family with two
pore-forming domains and four transmembrane segments (Fig.
1B). We placed the N terminus in the intracellular side,
similar to those of other tandem-pore K+ channels. Thus,
the putative K+ channel subunit has a short N terminus, an
extended extracellular loop between M1 and P1, and a long C terminus,
structural features typical of nearly all 4TM K+ channels
(Fig. 1C). Two N-glycosylation sites
(Asn144 and Asn147) are present in the
extracellular loop between M1 and P1. The amino acid sequence of the
new clone shows potential phosphorylation sites for protein kinases A
and C in the C terminus (Ser359 and Thr475) as
indicated.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 1.
TREK-2 sequences and predicted membrane
topology. A, nucleotide and amino acid sequences of rat
TREK-2. Four transmembrane segments and two pore-forming domains are
underlined. Consensus sites for N-glycosylation
(boxed) and phosphorylation by protein kinase A ( ) and protein kinase C ( ) are shown. These sites were
identified using the MacVector program. B, hydropathy plot
of TREK-2 amino acid sequence analyzed using the Kyte-Doolittle
algorithm (25) shows four potential transmembrane segments and two
potential pore-forming regions. C, deduced topology of
TREK-2. N-Gly, N-glycosylation; PKA
and PKC, protein kinase A and C, respectively.
|
|
Searching the GenBankTM Data Bank using the BLAST sequence
alignment program (26) identified a human homologue of rat TREK-2 in
the genomic sequences of chromosome 14 (accession numbers AL133279 and
AL122021) with 93% amino acid identity. The human TREK-2 DNA was
distributed in eight different locations with seven intervening sequences, as illustrated in the gene map (Fig.
2C). In the dbest data base,
we found one expressed sequence tag sequence (accession number
AI073392) of which 147 bp was similar to the M2 region of TREK-2
(851-991 bp of the open reading frame). The search also revealed that
the DNA sequence of the new clone is similar to those of TREK-1 and
TRAAK, which are 2P/4TM K+ channel subunits (10, 12).
Alignment of the DNA sequence of the new clone with those of TREK-1 and
TRAAK shows high homology within the transmembrane and pore-forming
domains (Fig. 2A). The new clone shares 65 and 45% amino
acid sequence identities with TREK-1 and TRAAK, respectively.
Therefore, the new clone is a third member of the TREK/TRAAK family of
4TM K+ channels. The dendrogram of all tandem-pore
K+ channels identified to date in the mammalian system is
shown in Fig. 2B. Rat TASK-3 (KCNK9) was just recently
identified in our laboratory (GenBankTM accession number
AF192366). The percentage indicates amino acid identity between two
subunits. Thus, closely related subunit groups exist within the 2P/4TM
K+ channel family such as TWIK, TASK, TREK, and KCNK6/7
groups. Homology between different groups of subunits is very low
(~20%).

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 2.
Alignment of amino acid sequences of TREK-2,
TREK-1, and TRAAK. A, three sequences are aligned, and
identical amino acids are boxed. Dashes indicate
gaps in alignment. Four transmembrane segments and two pore-forming
regions are indicated by solid lines above the amino acids.
B, a proposed phylogenetic tree of mammalian 4TM
K+ channels is shown. The percent values indicate amino
acid identity between two subunits. The accession number for TREK-2 is
AF196965. C, shown is a gene map of human TREK-2 based on
the three human chromosome 14 sequences (accession numbers AL133279,
AL122021, and AL049834). The first 51 bases of TREK-2 are located in
the AL049834 sequence. The map shows seven exons within the span of
~90 kb of DNA. The sizes of exons from left to right are 51, 57, 258, 122, 156, 188, 148, and 623 bp.
|
|
Tissue Distribution of TREK-2 mRNA--
The expression of
TREK-2 mRNA in adult rat tissues was examined by Northern blot
analysis and RT-PCR. TREK-2-specific primers were used to generate a
597-bp DNA fragment in the C terminus of TREK-2 and used as probe. The
first blot shows that of the eight tissues, the brain shows a distinct
band with an estimated size of 7.5 kb. Interestingly, a diffuse band
located between 3 and 5 kb was present in the pancreas. To further
localize the expression of TREK-2 within the brain, a blot in which
total RNAs from six different regions of rat brain were separated was
used. A major RNA transcript with an estimated size of ~7.5 kb was
detected in the cerebellum. RT-PCR was carried out to further determine the expression of TREK-2 mRNA in various tissues (Fig.
3B). The expected 597-bp PCR
products of TREK-2, confirmed by sequencing, were detected in three
tissues. The strongest signal was present in the cerebellum, confirming
the results of the Northern blot analysis. Spleen and testis showed
relatively weak signals. Control reactions performed in the absence of
reverse transcriptase in four tissue samples (cerebellum, spleen,
testis, and kidney) did not yield any visible bands under identical
conditions.

View larger version (75K):
[in this window]
[in a new window]
|
Fig. 3.
Tissue distribution of TREK-2 in the
rat. A, Northern blot analysis was performed using a
TREK-2-specific probe and -actin (control). The first blot
(CLONTECH) after 24 h of exposure shows a
major band at ~7.5 kb expressed in the brain. The second blot
(OriGene) after 36 h of exposure shows that, of the six regions of
the brain, the cerebellum expresses TREK-2 mRNA. Longer exposure (5 days) did not show any other distinct bands. B, reverse
transcriptase-PCR analysis of TASK-3 in rat tissues is shown. Total RNA
from each tissue was used to prepare first strand cDNAs.
TREK-2-specific primers were used to generate the expected PCR product
of 597 bp. The amplified PCR products were subcloned into the pCR2.1
vector (Invitrogen) and sequenced on one strand for confirmation. Two
controls (upper panel, last two lanes) included
one with no DNA and one with no enzyme. The quality of cDNA was
checked using glyceraldehyde-3-phosphate dehydrogenase
(G3DPH)-specific primers. Two controls included the template
DNA for glyceraldehyde-3-phosphate dehydrogenase and one that has no
DNA (lower panel, last two lanes).
|
|
Basic Electrophysiological and Pharmacological Properties--
To
determine whether TREK-2 forms a functional ion channel, the coding
region of TREK-2 was subcloned into a mammalian expression vector
(pcDNA3.1) and transiently transfected along with DNA that encodes
GFP into COS-7 cell. Fig. 4A
shows whole-cell currents recorded in nontransfected and transfected
COS-7 cells in bath solution containing 5 mM K+
and in pipette solution containing 150 mM K+.
Cell membrane potential was held at 80 mV and stepped to various potentials for 430-ms duration. Cells transfected with GFP alone showed
small currents of <200 pA (95 ± 40 pA at +20 mV,
n = 5). Cells that were transfected with TREK-2/GFP
showed instantaneous and non-inactivating currents in the nA range. The
averaged current at +20 mV in cells transfected with TREK-2 was
2.5 ± 0.9 nA (n = 4). Thus, TREK-2 forms a
functional ion channel in the plasma membrane of COS-7 cells.
Current-voltage relationships obtained from cells transfected with GFP
alone and GFP/TREK-2 are shown in Fig. 4B. In nontransfected
cells, the reversal potential was found to be close to zero ( 9 ± 7 mV, n = 4), indicating that only small background
leak current was present. The reversal potential shifted to 74 ± 4 mV (n = 3) after transfection with TREK-2, as
expected if functional K+ channels were expressed.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 4.
Expression of TREK-2 in COS-7 cells.
A, whole-cell currents were recorded from a cell transfected
with GFP only or with TREK-2/GFP. Pipette and bath solutions contained
150 and 5 mM KCl, respectively. The membrane potential was
held at 80 mV and stepped to various potentials ranging from 120 to
+20 mV. The dotted line indicates the zero
current level. B, current-voltage relationships are shown as
indicated (mean ± S.D. of three cells). C, outside-out
patches were formed, and [K+] in the bath solution
was changed as indicated. Ramp pulses ( 80 to +20 mV) were applied at
each [K+]. Typical tracings from one experiment are
shown. D, reversal potentials from three patches were
determined and are plotted as a function of [K+].
Experimental values were fitted by linear regression (slope, 53 mV/decade).
|
|
Ion selectivity of TREK-2 was studied using large outside-out patches
containing many channels by changing the concentration of
K+ in the bath solution from 5 to 150 mM while
maintaining the pipette [K+] constant at 150 mM. A voltage ramp from 80 to +20 mV was applied to the
patch, and currents from three trials were averaged for each
concentration of K+. The reversal potential shifted to the
right as [K+] in the bath solution was elevated, as
expected of an ion channel that is permeable to K+, but not
to Cl (Fig. 4C). A plot of the reversal
potential as a function of [K+]out showed
that the slope was 53 ± 2 mV (n = 4) per 10-fold
change in [K+]out, close to the calculated
Nernst value of 59 mV at 22 °C (Fig. 4D). In patches
obtained from cells transfected with GFP alone, a basal current level
of <5 pA was present at +20 mV. These results show that TREK-2 is a
relatively K+-selective ion channel, similar to other
two-pore K+ channels.
In cell-attached and inside-out patches, channel openings with marked
open channel noise were present in cells transfected with TREK-2/GFP,
but not with GFP alone. Channel openings at different membrane
potentials from an inside-out patch are shown in Fig. 5A when both pipette and bath
solutions contained 150 mM KCl. An open-time histogram was
determined from patches showing only one level of opening at 40 mV
such as that shown in Fig. 5A (Fig. 5B). The mean
open time of TREK-2 determined from five patches was 0.9 ± 0.1 ms. Mean open time at positive potentials could not be determined due
to clustered multiple openings. Amplitude histograms obtained from
channel openings at +40 and 40 mV are shown in Fig. 5C.
Despite the open channel noise, amplitude levels could be visually
identified, as indicated by dotted lines. Single-channel current-voltage relationship determined using the mean amplitude values
at different voltages shows that TREK-2 is an inwardly rectifying
K+ channel in symmetrical 150 mM
K+. The single-channel conductances were 68 ± 16 picosiemens at +40 mV and 110 ± 9 picosiemens at 40 mV
(n = 3) (Fig. 5D). TREK-2 channel activity
was always more active at depolarized than at hyperpolarized
potentials. Therefore, channel activities were determined at various
potentials from five patches and are plotted in Fig. 5E. The
data clearly show that the open probability increases as the cell
membrane depolarizes. This explains the linear or slightly outwardly
rectifying whole-cell current-voltage relationships of TREK-2 currents
in COS-7 cells (Fig. 4), despite the inward rectification of
single-channel currents.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 5.
Single-channel properties of TREK-2.
A, TREK-2 channels in an inside-out patch was recorded at
various membrane potentials as shown. c indicates the closed
state. The dotted lines indicate the open state
and were drawn by eye. B, a typical open-time histogram
determined from openings at 40 mV is shown. C, amplitude
histograms at two membrane potentials ( 40 and +40 mV) are shown.
D, current amplitudes from the first open level were
determined to obtain the current-voltage relationship (mean ± S.D. of three values). E, relative channel activity at
different membrane potentials is shown. In this experiment, the channel
activity at 60 mV was 0.10 ± 0.02 (n = 5) and
was taken as 1.0 for determining relative NPo at
other membrane potentials.
|
|
The effects of various pharmacological agents and pH were examined on
TREK-2 current using large outside-out patches from COS-7 cells in
symmetrical 150 mM KCl. TREK-2 was insensitive to low
concentrations of Ba2+ (100-500 µM) and
blocked only at high concentrations. Ba2+ at 2 mM applied extracellularly blocked the inward TREK-2
currents by 36 ± 5% ( 40 mV, n = 3). TREK-2 was
insensitive to 1 mM tetraethylammonium, 100 µM quinidine, 1 mM lidocaine, 100 µM bupivacaine, and 100 µM gadolinium when
applied extracellularly (<5% change; 80 and +80 mV,
n = 4 each). We examined the effect of changes in
intracellular pH on TREK-2 using inside-out patches. At 40 mV,
changes in pHi from 7.3 to 6.8 and 7.8 resulted in 4.0 ± 1.4- and 0.4 ± 0.2-fold changes from basal channel activity
observed at pH 7.3 (basal NPo = 0.17 ± 0.15, n = 8), respectively. Thus, TREK-2 is stimulated
markedly by acidic pH and inhibited mildly by alkaline pH.
TREK-2 possesses potential phosphorylation sites for both protein
kinases A and C. Therefore, the effects of activators of protein
kinases A and C were tested on TREK-2 in bath solution containing 5 mM K+ and 1 mM Ca2+
using cell-attached patch configuration. Membrane potential was held at
60 mV, and changes in channel activity was determined. Extracellular
application for 5 min of phorbol 12-myristate 13-acetate (100 nM), an activator of protein kinase C, failed to
significantly alter TREK-2 current in three cells. Application of
8-(4-chlorophenylthio)-cAMP (200 µM), a permeant
derivative of cAMP, to increase intracellular cAMP levels resulted in a
66 ± 13% (n = 4) decrease in channel activity at
the end of a 3-min period. This inhibition by
8-(4-chlorophenylthio)-cAMP was reduced by 58 ± 12%
(n = 3) by pretreatment with H-7 (25 µM), a protein kinase A inhibitor. Application of
1-methyl-3-isobutylxanthine (200 µM), which should also
increase cAMP concentration in the cell and activate protein kinase A,
resulted in 85 ± 5% (n = 3) inhibition of
channel activity after 3 min of perfusion. Thus, phosphorylation by
protein kinase A caused a significant reduction of TREK-2 current,
whereas phosphorylation by protein kinase C had no effect.
Mechanosensitivity of TREK-2--
Whether TREK-2 is sensitive to
membrane stretch was assessed by applying negative pressure to the
patch membrane. In cell-attached patches, a basal level of channel
activity was usually present under normal atmospheric pressure.
Applying negative pressure ( 40 mm Hg) to the patch membrane increased
channel activity in every cell that contained TREK-2. In 11 out of 12 patches obtained from cells transfected with GFP only, application of
negative pressure even up to 80 mm Hg failed to activate channels. In
one patch, a small conductance channel (15 picosiemens) was activated by negative pressure. In inside-out patches from cells transfected with
TREK-2, the basal activity at atmospheric pressure was also observed,
but tended to be higher than that in the cell-attached patch in most
patches. Using inside-out patches with relatively low basal activity,
we tested the effect of negative pressure on TREK-2. At a holding
potential of 40 mV, application of negative pressure (0 to 80 mm
Hg) produced a rapid increase in channel activity in every patch
studied (Fig. 6A). Return of
pressure to the atmospheric level (0 mm Hg) resulted in a quick return of TREK-2 to basal activity. No desensitization of channel activity was
observed when the negative pressure ( 40 mm Hg) was held constant for
>3 min. Relative channel activity plotted as a function of applied
pressure is shown in Fig. 6B. We were unable to determine channel activity at pressures less than 80 mm Hg, as patches became
leaky and eventually broke. Therefore, the pressure at which
half-maximal activation occurs could not be determined. These results
show that TREK-2, like TREK-1 and TRAAK, is a mechanosensitive K+ channel.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 6.
Mechanosensitivity of TREK-2.
A, inside-out patches were formed, and then negative
pressure (0 to 80 mm Hg) was applied to the patch membrane. Patches
that showed low basal channel activity at atmospheric pressure were
used. Activation by pressure was reversible in every patch. The holding
potential was 40 mV. B, channel activity at 80 mm Hg was
taken as 1.0, and relative channel activities at various pressures were
then plotted as a function of pressure. Each point is the mean ± S.D. of three determinations. Asterisks indicate a
significant difference from the value at atmospheric pressure (0 mm
Hg).
|
|
Activation of TREK-2 by Free Fatty Acids--
Whether TREK-2 is
sensitive to free fatty acids was tested using inside-out and
outside-out patches. As shown in Fig.
7A, arachidonic acid (AA)
increased channel activity in a concentration-dependent manner when applied to the cytoplasmic side of inside-out patches. Onset of activation was generally rapid, and steady-state activation was observed within 30 s after application. High concentrations of
AA (30-50 µM) did not further increase channel activity
above that produced by 20 µM and generally caused patches
to become unstable and leaky. In Fig. 7B, relative channel
activities were plotted as a function of [AA]. With the reasonable
assumption that 20 µM AA produces maximal activation of
TREK-2, averaged data from eight patches were fitted to a Hill equation
of the following form: y = 1/(1 + (K1/2/[AA])n), where
K1/2 is the apparent concentration of AA that
produces half-maximal activation and n is the Hill coefficient (apparent K1/2 = 7.3 µM,
Hill coefficient = 2.2). We tested whether other free fatty acids
are also able to activate TREK-2. When applied to the cytoplasmic side
of inside-out patches, docosahexaenoic acid, eicosapentaenoic acid,
linolenic acid, linoleic acid, and oleic acid all strongly and
reversibly stimulated TREK-2 current at 20 µM (Fig.
7C). Elaidic acid, the trans-isomer of
cis-oleic acid, failed to activate TREK-2, indicating that
structural specificity exists for TREK-2 activation. Saturated free
fatty acids such as stearic acid and palmitic acid did not increase
TREK-2 channel activity even up to 100 µM. We also tested
whether free fatty acids could activate TREK-2 from the extracellular
side of the membrane. In outside-out patches, extracellular application
of linoleic and oleic acids caused 9 ± 3- and 6 ± 2-fold
increases above the basal level, respectively (n = 3 each). Elaidic acid, stearic acid, and palmitic acid failed to
significantly increase TREK-2 activity from the extracellular side of
the membrane (<2% change from three patches each). Examples of
activation by AA, linoleic acid, and oleic acid in inside-out and
outside-out patches are shown in Fig. 7D. These results show that TREK-2 is activated by long-chain unsaturated free fatty acids.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 7.
Activation of TREK-2 by free fatty acids in
COS-7 cells. A, in an inside-out patch, AA was applied
to the cytoplasmic side of the membrane. The concentration of AA was
increased in steps from 0 to 20 µM. B,
relative channel activity is plotted as a function of [AA]. Channel
activity determined at 20 µM AA was taken as 1.0. Each
point is the mean ± S.D. of eight values. The points were fitted
to the Hill equation to obtain the apparent K1/2
(7.3 µM) and Hill coefficient (2.2). C, shown
is the percent increase in TREK-2 activity by different free fatty
acids applied at 20 µM (n = 3 each). AA,
docosahexaenoic acid (DHA), eicosapentaenoic acid
(EPA), linoleic acid (LA), linolenic acid
(LNA), oleic acid (OA), elaidic acid
(EA), stearic acid (SA), and palmitic acid
(PA) were used. D, examples of reversible
activation by AA, linoleic acid, and oleic acid in inside-out and
outside-out patches are shown as indicated. W/O,
washout.
|
|
 |
DISCUSSION |
In this study, we report the cloning and expression of TREK-2, a
new member of the 2P/4TM K+ channel family. TREK-2 forms a
functional K+ channel when expressed in COS-7 cells and is
activated by membrane stretch and unsaturated free fatty acids, a
hallmark of the TREK/TRAAK group of the 2P/4TM K+ channel
subfamily (12, 19, 20). In the rat, the distribution of TREK-2 mRNA
was mainly in the cerebellum, suggesting that TREK-2 may have a unique
role in this part of the brain.
Native KFA Channels and TREK/TRAAK--
We have
previously identified and characterized a family of K+
channels in cardiac and neuronal cells and have referred to them as
KAA and KFA channels, as they were activated by
arachidonic acid and other free fatty acids (23, 24, 27). It was also found that membrane stretch can cause activation of these
K+ channels (24, 28). K+ channels with similar
properties were also identified in smooth muscle cells and in a colonic
secretory cell line (21, 29). The gating kinetics of the
KFA channels are unique in that they show extremely high
open channel noise even in the absence of any channel blocker or
divalent cations. Furthermore, none of the organic K+
channel blockers tested (1 mM) caused a significant
inhibition of K+ channel activity. Therefore, the
KFA channels were thought to belong to a new family of
K+ channels with distinct function and structure. Recent
cloning and expression studies show that the TREK/TRAAK members of the 2P/4TM K+ channel family are likely to encode the
KFA channels. TREK-1 and TRAAK have been shown to be
activated by membrane stretch and free fatty acids and have biophysical
properties similar to those of native KFA channels. Thus,
both KFA channels and TREK/TRAAK show marked open channel
noise, opening in bursts, lack of block by organic K+
channel blockers, and large single-channel conductance (100-130 picosiemens at negative potentials).
We have previously identified in isolated neurons from rat brain three
different types of KFA channels by applying either suction
or free fatty acids (24). The current-voltage relationships of the
three KFA channels were outwardly rectifying, inwardly rectifying, and linear, allowing unambiguous identification of each
type of KFA channel. TREK-1 shows an outwardly rectifying single-channel current-voltage relationship in high [K+]
solution, with conductances similar to those of the native
KFA channel (10, 30). Single channels of TREK-2, on the
other hand, shows clear inwardly rectifying behavior in high
[K+] solution, with conductances similar to those of
another native KFA channel described earlier (24).
Therefore, TREK-1 and TREK-2 probably represent two of the three
KFA channels that we have identified in the neurons. At
present, a native KFA channel whose single-channel kinetic
properties are similar to those of TRAAK has not yet been described.
Activation by Pressure and Free Fatty Acids--
When TREK-2 is
expressed in mammalian cells such as COS-7 cells, a basal level of
channel activity is normally present. Similarly, TREK-1 exhibits some
basal current when expressed in COS cells (10, 19). The basal current
that is present at resting membrane potential is expected to drive the
membrane potential toward the K+ equilibrium potential.
TREK/TRAAK current is activated instantaneously by a voltage step, does
not inactivate with time, and shows no voltage threshold for
activation. These properties of TREK/TRAAK suggest that they would
serve as background currents that help to set the resting membrane
potential. In addition, they might serve as sensors for changes in
osmotic pressure and free fatty acids and be involved in mechano- and
metabolism-electrical coupling, respectively. Mechanosensitive ion
channels have been identified in various mammalian cell types, but how
membrane tension opens and modulates ion channels is not known
(31-35).
In summary, we have cloned TREK-2, an inwardly rectifying
K+ channel that belongs to the 2P/4TM K+
channel family. The biophysical properties of TREK-2, together with its
sensitivity to membrane stretch and free fatty acids, indicate that the
TREK-2 gene probably encodes an inwardly rectifying KFA channel that we have identified earlier in neurons. The
physiological significance of KFA/TREK/TRAAK channels is
not evident at present, although they are expected to be involved in
the regulation of resting membrane potential, if they are active at
rest in vivo. One could speculate that activation of these
channels in specific tissues might help to protect the cell against
damage produced by hypoxia or ischemia, which causes a rise in
intracellular free fatty acids and cell swelling and intracellular
acidosis (36-39). Further studies are clearly needed to address this
important question.
 |
FOOTNOTES |
*
This work was supported by a grant-in-aid from the American
Heart Association.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF196965.
Present address: Dept. of Physiology, Chung-Ang University College
of Medicine, Seoul 156-756, Korea.
§
To whom correspondence should be addressed: Dept. of Physiology and
Biophysics, Finch University of Health Sciences/The Chicago Medical
School, 3333 Green Bay Rd., North Chicago, IL 60064. Tel.: 847-578-3280; Fax: 847-578-3265; E-mail:
donghee.kim@finchcms.edu.
Published, JBC Papers in Press, March 31, 2000, DOI 10.1074/jbc.M000445200
2
TREK-2 has been assigned the gene name
KCNK10 (approved by the Human Genome Organization).
 |
ABBREVIATIONS |
The abbreviations used are:
2P, two pore;
4TM, four transmembrane;
bp, base pair(s);
RT-PCR, reverse
transcriptase-polymerase chain reaction;
kb, kilobase(s);
GFP, green
fluorescent protein;
AA, arachidonic acid.
 |
REFERENCES |
| 1.
|
Pongs, O.
(1992)
Physiol. Rev.
72,
569-588
|
| 2.
|
Jan, L. Y.,
and Jan, Y. N.
(1994)
Nature
371,
119-122
|
| 3.
|
Wei, A.,
Jegla, T.,
and Salkoff, L.
(1996)
Neuropharmacology
35,
805-829
|
| 4.
|
Heginbotham, L.,
Lu, Z.,
Abramson, T.,
and Mackinnon, R.
(1994)
Biophys. J.
66,
1061-1067
|
| 5.
|
Doyle, D. A.,
Morais, J.,
Pfuetzner, R. A.,
Kuo, A.,
Gulbis, J. M.,
Cohen, S. L.,
Chait, B. T.,
and Mackinnon, R.
(1998)
Science
280,
69-77
|
| 6.
|
Goldstein, S. N.,
Price, L. A.,
Rosenthal, D. N.,
and Pausch, M. H.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
13256-13261
|
| 7.
|
Lesage, F.,
Guillemare, E.,
Fink, M.,
Duprat, F.,
Lazdunski, M.,
Romey, G.,
and Barhanin, J.
(1996)
EMBO J.
15,
1004-1011
|
| 8.
|
Goldstein, S. A. N.,
Wang, K.-W.,
Ilan, N.,
and Pausch, M. H.
(1998)
J. Mol. Med.
76,
13-20
|
| 9.
|
Wang, Z. W.,
Kunkel, M. T.,
Wei, A.,
Butler, A.,
and Salkoff, L.
(1999)
Ann. N. Y. Acad. Sci.
868,
286-303
|
| 10.
|
Fink, M.,
Duprat, F.,
Lesage, F.,
Reyes, R.,
Romey, G.,
Heurteaux, C.,
and Lazdunski, M.
(1996)
EMBO J.
15,
6854-6862
|
| 11.
|
Duprat, M.,
Lesage, F.,
Fink, M.,
Reyes, R.,
Heurteaux, C.,
and Lazdunski, M.
(1997)
EMBO J.
16,
5464-5471
|
| 12.
|
Fink, M.,
Lesage, F.,
Duprat, F.,
Heurteaux, C.,
Reyes, R.,
Fosset, M.,
and Lazdunski, M.
(1998)
EMBO J.
17,
3297-3308
|
| 13.
|
Leonoudakis, D.,
Gray, A. T.,
Winegar, B. D.,
Kindler, C. H.,
Harada, M.,
Taylor, D. M.,
Chavez, R. A.,
Forsayeth, J. R.,
and Yost, C. S.
(1998)
J. Neurosci.
18,
868-877
|
| 14.
|
Reyes, R.,
Duprat, F.,
Lesage, F.,
Fink, M.,
Salinas, M.,
Farman, N.,
and Lazdunski, M.
(1998)
J. Biol. Chem.
273,
30863-30869
|
| 15.
|
Kim, Y.,
Bang, H. W.,
and Kim, D.
(1999)
Am. J. Physiol.
277,
H1669-H1678
|
| 16.
|
Chavez, R. A.,
Gray, A. T.,
Zhao, B. B.,
Kindler, C. H.,
Mazurek, M. J.,
Mehta, Y.,
Forsayeth, J. R.,
and Yost, C. S.
(1999)
J. Biol. Chem.
274,
7887-7892
|
| 17.
|
Pountney, D. J.,
Gulkarov, I.,
Vega-Saenz de Miera, E.,
Holmes, D.,
Saganich, M.,
Rudy, B.,
Artman, M.,
and Coetzee, W. A.
(1999)
FEBS Lett.
450,
191-196
|
| 18.
|
Salinas, M.,
Reyes, R.,
Lesage, F.,
Fosset, M.,
Heurteaux, C.,
Romey, G.,
and Lazdunski, M.
(1999)
J. Biol. Chem.
274,
11751-11760
|
| 19.
|
Patel, A. J.,
Honore, E.,
Maingret, F.,
Lesage, F.,
Fink, M.,
Duprat, F.,
and Lazdunski, M.
(1998)
EMBO J.
17,
4283-4290
|
| 20.
|
Maingret, F.,
Fosset, M.,
Lesage, F.,
Lazdunski, M.,
and Honore, E.
(1999)
J. Biol. Chem.
274,
1381-1387
|
| 21.
|
Ordway, R. W.,
Walsh, J. V., Jr.,
and Singer, J. J.
(1989)
Science
244,
1176-1179
|
| 22.
|
Premkumar, L. S.,
Gage, P. W.,
and Chung, S. H.
(1990)
Proc. R. Soc. Lond. B Biol. Sci.
242,
17-22
|
| 23.
|
Kim, D.,
and Duff, R.
(1990)
Circ. Res.
67,
1040-1046
|
| 24.
|
Kim, D.,
Sladek, C. D.,
Aguado-Velasco, C.,
and Mathiasen, J. R.
(1995)
J. Physiol. (Lond.)
484.3,
643-660
|
| 25.
|
Kyte, J.,
and Doolittle, R.
(1982)
J. Mol. Biol.
157,
162-166
|
| 26.
|
Altschul, S. F.,
Gish, W.,
Miller, W.,
Myers, E. W.,
and Lipman, D. J.
(1990)
J. Mol. Biol.
215,
403-410
|
| 27.
|
Kim, D.,
and Clapham, D. E.
(1989)
Science
244,
1174-1176
|
| 28.
|
Kim, D.
(1992)
J. Gen. Physiol.
100,
1-20
|
| 29.
|
Devor, D. C.,
and Frizzell, R. A.
(1998)
Am. J. Physiol.
274,
C149-C160
|
| 30.
|
Maingret, F.,
Patel, A. J.,
Lesage, F.,
Lazdunski, M.,
and Honore, E.
(1999)
J. Biol. Chem.
274,
26691-26696
|
| 31.
|
Sachs, F.
(1986)
Membr. Biochem.
6,
173-195
|
| 32.
|
Morris, C. E.
(1990)
J. Membr. Biol.
113,
93-107
|
| 33.
|
Sackin, H.
(1995)
Annu. Rev. Physiol.
57,
333-353
|
| 34.
|
Chang, G.,
Spencer, R. H.,
Lee, A. T.,
Barclay, M. T.,
and Rees, D. C.
(1998)
Science
282,
2220-2226
|
| 35.
|
Ou, X.,
Blount, P.,
Hoffman, R. J.,
and Kung, C.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
11471-11475
|
| 36.
|
Bazan, N. G. J.,
Bazan, H. E. P.,
Kennedy, W. G.,
and Joel, C. D.
(1971)
J. Neurochem.
18,
1387-1393
|
| 37.
|
Siesjo, B. K.
(1988)
Neurochem. Pathol.
9,
31-88
|
| 38.
|
VanderVusse, G. J.,
Glatz, J. F.,
Stam, H. C.,
and Reneman, R. S.
(1992)
Physiol. Rev.
72,
881-940
|
| 39.
|
Lipton, P.
(1999)
Physiol. Rev.
79,
1431-1568
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Zheng, J. H. Nam, B. Pang, D. H. Shin, J. S. Kim, Y.-S. Chun, J.-W. Park, H. Bang, W. K. Kim, Y. E. Earm, et al.
Identification of the large-conductance background K+ channel in mouse B cells as TREK-2
Am J Physiol Cell Physiol,
July 1, 2009;
297(1):
C188 - C197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Xiao, P.-Y. Deng, L. Rojanathammanee, C. Yang, L. Grisanti, K. Permpoonputtana, D. Weinshenker, V. A. Doze, J. E. Porter, and S. Lei
Noradrenergic Depression of Neuronal Excitability in the Entorhinal Cortex via Activation of TREK-2 K+ Channels
J. Biol. Chem.,
April 17, 2009;
284(16):
10980 - 10991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Simkin, E. J. Cavanaugh, and D. Kim
Control of the single channel conductance of K2P10.1 (TREK-2) by the amino-terminus: role of alternative translation initiation
J. Physiol.,
December 1, 2008;
586(23):
5651 - 5663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Sandoz, M. P. Tardy, S. Thummler, S. Feliciangeli, M. Lazdunski, and F. Lesage
Mtap2 Is a Constituent of the Protein Network That Regulates Twik-Related K+ Channel Expression and Trafficking
J. Neurosci.,
August 20, 2008;
28(34):
8545 - 8552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Heitzmann and R. Warth
Physiology and Pathophysiology of Potassium Channels in Gastrointestinal Epithelia
Physiol Rev,
July 1, 2008;
88(3):
1119 - 1182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pokojski, C. Busch, I. Grgic, M. Kacik, W. Salman, R. Preisig-Muller, W.-T. Heyken, J. Daut, J. Hoyer, and R. Kohler
TWIK-related two-pore domain potassium channel TREK-1 in carotid endothelium of normotensive and hypertensive mice
Cardiovasc Res,
April 3, 2008;
(2008)
cvn069v2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kang, C. Choe, E. Cavanaugh, and D. Kim
Properties of single two-pore domain TREK-2 channels expressed in mammalian cells
J. Physiol.,
August 15, 2007;
583(1):
57 - 69.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mathie
Neuronal two-pore-domain potassium channels and their regulation by G protein-coupled receptors
J. Physiol.,
January 15, 2007;
578(2):
377 - 385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kang, J. Han, and D. Kim
Mechanism of inhibition of TREK-2 (K2P10.1) by the Gq-coupled M3 muscarinic receptor
Am J Physiol Cell Physiol,
October 1, 2006;
291(4):
C649 - C656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Brock, M. C. Acosta, A. Al Abed, S. Pianova, and C. Belmonte
Barium ions inhibit the dynamic response of guinea-pig corneal cold receptors to heating but not to cooling
J. Physiol.,
September 1, 2006;
575(2):
573 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Bryan Jr., J. You, S. C. Phillips, J. J. Andresen, E. E. Lloyd, P. A. Rogers, S. E. Dryer, and S. P. Marrelli
Evidence for two-pore domain potassium channels in rat cerebral arteries
Am J Physiol Heart Circ Physiol,
August 1, 2006;
291(2):
H770 - H780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Honore, A. J. Patel, J. Chemin, T. Suchyna, and F. Sachs
Desensitization of mechano-gated K2P channels
PNAS,
May 2, 2006;
103(18):
6859 - 6864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Sanders and S. Don Koh
Two-pore-domain potassium channels in smooth muscles: new components of myogenic regulation
J. Physiol.,
January 1, 2006;
570(1):
37 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Taverna, T. Tkatch, A. E. Metz, and M. Martina
Differential Expression of TASK Channels between Horizontal Interneurons and Pyramidal Cells of Rat Hippocampus
J. Neurosci.,
October 5, 2005;
25(40):
9162 - 9170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Enyeart, S. J. Danthi, H. Liu, and J. A. Enyeart
Angiotensin II Inhibits bTREK-1 K+ Channels in Adrenocortical Cells by Separate Ca2+- and ATP Hydrolysis-dependent Mechanisms
J. Biol. Chem.,
September 2, 2005;
280(35):
30814 - 30828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Kim, J.-Y. Park, H.-W. Kang, E.-J. Lee, H. Bang, and J.-H. Lee
Zinc Activates TREK-2 Potassium Channel Activity
J. Pharmacol. Exp. Ther.,
August 1, 2005;
314(2):
618 - 625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Bai, G. J Bugg, S. L Greenwood, J. D Glazier, C. P Sibley, P. N Baker, M. J Taggart, and G. K Fyfe
Expression of TASK and TREK, two-pore domain K+ channels, in human myometrium
Reproduction,
April 1, 2005;
129(4):
525 - 530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kang, C. Choe, and D. Kim
Thermosensitivity of the two-pore domain K+ channels TREK-2 and TRAAK
J. Physiol.,
April 1, 2005;
564(1):
103 - 116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chemin, A. Patel, F. Duprat, M. Zanzouri, M. Lazdunski, and E. Honore
Lysophosphatidic Acid-operated K+ Channels
J. Biol. Chem.,
February 11, 2005;
280(6):
4415 - 4421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Bai, S. L. Greenwood, J. D. Glazier, P. N. Baker, C. P. Sibley, M. J. Taggart, and G. K. Fyfe
Localization of TASK and TREK, Two-Pore Domain K+ Channels, in Human Cytotrophoblast Cells
Reproductive Sciences,
February 1, 2005;
12(2):
77 - 83.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Hebert, G. Desir, G. Giebisch, and W. Wang
Molecular Diversity and Regulation of Renal Potassium Channels
Physiol Rev,
January 1, 2005;
85(1):
319 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Duprat, C. Girard, G. Jarretou, and M. Lazdunski
Pancreatic two P domain K+ channels TALK-1 and TALK-2 are activated by nitric oxide and reactive oxygen species
J. Physiol.,
January 1, 2005;
562(1):
235 - 244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Ander, A. R. Weber, P. P. Rampersad, J. S. C. Gilchrist, G. N. Pierce, and A. Lukas
Dietary Flaxseed Protects against Ventricular Fibrillation Induced by Ischemia-Reperfusion in Normal and Hypercholesterolemic Rabbits
J. Nutr.,
December 1, 2004;
134(12):
3250 - 3256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kang, E. Mariash, and D. Kim
Functional Expression of TRESK-2, a New Member of the Tandem-pore K+ Channel Family
J. Biol. Chem.,
July 2, 2004;
279(27):
28063 - 28070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Nam, J.-E. Woo, D.-Y. Uhm, and S. J. Kim
Membrane-delimited Regulation of Novel Background K+ Channels by MgATP in Murine Immature B Cells
J. Biol. Chem.,
May 14, 2004;
279(20):
20643 - 20654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Czirjak, Z. E. Toth, and P. Enyedi
The Two-pore Domain K+ Channel, TRESK, Is Activated by the Cytoplasmic Calcium Signal through Calcineurin
J. Biol. Chem.,
April 30, 2004;
279(18):
18550 - 18558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Han, D. Kang, and D. Kim
Functional properties of four splice variants of a human pancreatic tandem-pore K+ channel, TALK-1
Am J Physiol Cell Physiol,
September 1, 2003;
285(3):
C529 - C538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sano, K. Inamura, A. Miyake, S. Mochizuki, C. Kitada, H. Yokoi, K. Nozawa, H. Okada, H. Matsushime, and K. Furuichi
A Novel Two-pore Domain K+ Channel, TRESK, Is Localized in the Spinal Cord
J. Biol. Chem.,
July 18, 2003;
278(30):
27406 - 27412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Miller, P J Kemp, A Lewis, C G Chapman, H J Meadows, and C Peers
Acute hypoxia occludes hTREK-1 modulation: re-evaluation of the potential role of tandem P domain K+ channels in central neuroprotection
J. Physiol.,
April 1, 2003;
548(1):
31 - 37.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Talley, J. E. Sirois, Q. Lei, and D. A. Bayliss
Two-Pore-Domain (Kcnk) Potassium Channels: Dynamic Roles in Neuronal Function
Neuroscientist,
February 1, 2003;
9(1):
46 - 56.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Han, C. Gnatenco, C. D Sladek, and D. Kim
Background and tandem-pore potassium channels in magnocellular neurosecretory cells of the rat supraoptic nucleus
J. Physiol.,
February 1, 2003;
546(3):
625 - 639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Enyeart, L. Xu, S. Danthi, and J. A. Enyeart
An ACTH- and ATP-regulated Background K+ Channel in Adrenocortical Cells Is TREK-1
J. Biol. Chem.,
December 13, 2002;
277(51):
49186 - 49199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J Allen and D. Attwell
Modulation of ASIC channels in rat cerebellar purkinje neurons by ischaemia-related signals
J. Physiol.,
September 1, 2002;
543(2):
521 - 529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Lyford, P. R. Strege, A. Shepard, Y. Ou, L. Ermilov, S. M. Miller, S. J. Gibbons, J. L. Rae, J. H. Szurszewski, and G. Farrugia
alpha 1C (CaV1.2) L-type calcium channel mediates mechanosensitive calcium regulation
Am J Physiol Cell Physiol,
September 1, 2002;
283(3):
C1001 - C1008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Han, J. Truell, C. Gnatenco, and D. Kim
Characterization of four types of background potassium channels in rat cerebellar granule neurons
J. Physiol.,
July 15, 2002;
542(2):
431 - 444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Gu, G. Schlichthorl, J. R Hirsch, H. Engels, C. Karschin, A. Karschin, C. Derst, O. K Steinlein, and J. Daut
Expression pattern and functional characteristics of two novel splice variants of the two-pore-domain potassium channel TREK-2
J. Physiol.,
March 15, 2002;
539(3):
657 - 668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Talley, G. Solorzano, Q. Lei, D. Kim, and D. A. Bayliss
CNS Distribution of Members of the Two-Pore-Domain (KCNK) Potassium Channel Family
J. Neurosci.,
October 1, 2001;
21(19):
7491 - 7505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. P. Hamill and B. Martinac
Molecular Basis of Mechanotransduction in Living Cells
Physiol Rev,
April 1, 2001;
81(2):
685 - 740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Lesage, C. Terrenoire, G. Romey, and M. Lazdunski
Human TREK2, a 2P Domain Mechano-sensitive K+ Channel with Multiple Regulations by Polyunsaturated Fatty Acids, Lysophospholipids, and Gs, Gi, and Gq Protein-coupled Receptors
J. Biol. Chem.,
September 8, 2000;
275(37):
28398 - 28405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Patel, F. Maingret, V. Magnone, M. Fosset, M. Lazdunski, and E. Honore
TWIK-2, an Inactivating 2P Domain K+ Channel
J. Biol. Chem.,
September 8, 2000;
275(37):
28722 - 28730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rajan, E. Wischmeyer, C. Karschin, R. Preisig-Muller, K.-H. Grzeschik, J. Daut, A. Karschin, and C. Derst
THIK-1 and THIK-2, a Novel Subfamily of Tandem Pore Domain K+ Channels
J. Biol. Chem.,
March 2, 2001;
276(10):
7302 - 7311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Czirjak and P. Enyedi
Formation of Functional Heterodimers between the TASK-1 and TASK-3 Two-pore Domain Potassium Channel Subunits
J. Biol. Chem.,
February 8, 2002;
277(7):
5426 - 5432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Gu, G. Schlichthorl, J. R. Hirsch, H. Engels, C. Karschin, A. Karschin, C. Derst, O. K. Steinlein, and J. Daut
Expression pattern and functional characteristics of two novel splice variants of the two-pore-domain potassium channel TREK-2
J. Physiol.,
February 8, 2002;
(2002)
200101343.
[Abstract]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|